Detecting biological heterogeneity patterns in ADNI amnestic mild cognitive impairment based on volumetric MRI

There is substantial biological heterogeneity among older adults with amnestic mild cognitive impairment (aMCI). We hypothesized that this heterogeneity can be detected solely based on volumetric MRI measures, which potentially have clinical implications and can improve our ability to predict clinical outcomes. We used latent class analysis (LCA) to identify subgroups among persons with aMCI ( n  = 696) enrolled in the Alzheimer’s Disease Neuroimaging Initiative (ADNI), based on baseline volumetric MRI measures. We used volumetric measures of 10 different brain regions. The subgroups were validated with respect to demographics, cognitive performance, and other AD biomarkers. The subgroups were compared with each other and with normal and Alzheimer’s disease (AD) groups with respect to baseline cognitive function and longitudinal rate of conversion. Four aMCI subgroups emerged with distinct MRI patterns: The first subgroup ( n  = 404), most similar to normal controls in volumetric characteristics and cognitive function, had the lowest incidence of AD. The second subgroup ( n  = 230) had the most similar MRI profile to early AD, along with poor performance in memory and executive function domains. The third subgroup ( n  = 36) had the highest global atrophy, very small hippocampus and worst overall cognitive performance. The fourth subgroup ( n  = 26) had the least amount of atrophy, however still had poor cognitive function specifically in in the executive function domain. Individuals with aMCI who were clinically categorized within one group other showed substantial heterogeneity based on MRI volumetric measures.

[1]  D. Wechsler,et al.  Wechsler Adult Intelligence Scale—Fourth Edition (WAIS-IV) , 2010 .

[2]  Y. Stern.  What is cognitive reserve? Theory and research application of the reserve concept , 2002, Journal of the International Neuropsychological Society.

[3]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[4]  Jessica A. Grahn,et al.  The cognitive functions of the caudate nucleus , 2008, Progress in Neurobiology.

[5]  D. Bennett,et al.  Class-Specific Incidence of All-Cause Dementia and Alzheimer's Disease: A Latent Class Approach. , 2018, Journal of Alzheimer's disease : JAD.

[6]  Philip S. Insel,et al.  Development and assessment of a composite score for memory in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) , 2012, Brain Imaging and Behavior.

[7]  D. Salmon,et al.  Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. , 2014, Journal of Alzheimer's disease : JAD.

[8]  R. Mayeux,et al.  Hippocampal and entorhinal atrophy in mild cognitive impairment , 2007, Neurology.

[9]  J. Cummings,et al.  Mild cognitive impairment (MCI) represents early-stage Alzheimer's disease. , 2005, Journal of Alzheimer's disease : JAD.

[10]  Jakub Jończyk,et al.  Therapeutic strategies for Alzheimer’s disease in clinical trials , 2016, Pharmacological reports : PR.

[11]  J. E. Partington,et al.  Partington's Pathways Test. , 2020 .

[12]  C. Jack,et al.  MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment , 2008, Neurology.

[13]  Evan Fletcher,et al.  Fully-Automated White Matter Hyperintensity Detection with Anatomical Prior Knowledge and without FLAIR , 2009, IPMI.

[14]  M. Albert,et al.  Amnestic MCI or prodromal Alzheimer's disease? , 2004, The Lancet Neurology.

[15]  A. Dale,et al.  Regional rates of neocortical atrophy from normal aging to early Alzheimer disease , 2009, Neurology.

[16]  H. Chui,et al.  Understanding hippocampal sclerosis in the elderly: Epidemiology, characterization, and diagnostic issues , 2008, Current neurology and neuroscience reports.

[17]  Jeannie-Marie S. Leoutsakos,et al.  Latent Classes of Neuropsychiatric Symptoms in NACC Controls and Conversion to Mild Cognitive Impairment or Dementia. , 2015, Journal of Alzheimer's disease : JAD.

[18]  B. Muthén,et al.  Deciding on the Number of Classes in Latent Class Analysis and Growth Mixture Modeling: A Monte Carlo Simulation Study , 2007 .

[19]  C. Jack,et al.  Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects , 2010, Alzheimer's & Dementia.

[20]  R. Lipton,et al.  Identification of Heterogeneous Cognitive Subgroups in Community-Dwelling Older Adults: A Latent Class Analysis of the Einstein Aging Study , 2018, Journal of the International Neuropsychological Society.

[21]  P. Mecocci,et al.  Clinical trials and late‐stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014 , 2014, Journal of internal medicine.

[22]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[23]  Nicholas F. Benson,et al.  Independent examination of the Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV): what does the WAIS-IV measure? , 2010, Psychological assessment.

[24]  A. Raftery.  Bayesian Model Selection in Social Research , 1995 .

[25]  Wenyaw Chan,et al.  Statistical Methods in Medical Research , 2013, Model. Assist. Stat. Appl..

[26]  P. Rubé,et al.  L’examen Clinique en Psychologie , 1959 .

[27]  Adrienne Nishina,et al.  Subtypes, severity, and structural stability of peer victimization: what does latent class analysis say? , 2007, Child development.

[28]  C. Jack,et al.  Ways toward an early diagnosis in Alzheimer’s disease: The Alzheimer’s Disease Neuroimaging Initiative (ADNI) , 2005, Alzheimer's & Dementia.

[29]  K. Ball,et al.  Long-term effects of cognitive training on everyday functional outcomes in older adults. , 2006, JAMA.

[30]  Charles DeCarli,et al.  Biological heterogeneity in ADNI amnestic mild cognitive impairment , 2014, Alzheimer's & Dementia.

[31]  George W Rebok,et al.  Effects of cognitive training interventions with older adults: a randomized controlled trial. , 2002, JAMA.

[32]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .

[33]  G. Celeux,et al.  An entropy criterion for assessing the number of clusters in a mixture model , 1996 .

[34]  M. Bondi,et al.  Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors , 2015, Alzheimer's & Dementia.

[35]  D. Bennett,et al.  Subtypes Based on Neuropsychological Performance Predict Incident Dementia: Findings from the Rush Memory and Aging Project. , 2019, Journal of Alzheimer's disease : JAD.

[36]  R. Petersen,et al.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects , 2009, Annals of neurology.

[37]  I. Veer,et al.  Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study , 2008, Brain : a journal of neurology.

[38]  M. Bondi,et al.  Statistically Derived Subtypes and Associations with Cerebrospinal Fluid and Genetic Biomarkers in Mild Cognitive Impairment: A Latent Profile Analysis , 2017, Journal of the International Neuropsychological Society.

[39]  D. Nagin,et al.  What Has Been Learned from Group-Based Trajectory Modeling? Examples from Physical Aggression and Other Problem Behaviors , 2005 .

[40]  Cindee M. Madison,et al.  Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI , 2011, Neurobiology of Aging.

[41]  T. Beauchaine,et al.  Taxometrics and developmental psychopathology , 2003, Development and Psychopathology.

[42]  Leslie M. Shaw,et al.  PENN Biomarker Core of the Alzheimer’s Disease Neuroimaging Initiative , 2007, Neurosignals.

[43]  Philip S. Insel,et al.  A composite score for executive functioning, validated in Alzheimer’s Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment , 2012, Brain Imaging and Behavior.